Ignite Creation Date:
2025-12-24 @ 1:37 PM
Ignite Modification Date:
2025-12-28 @ 10:58 AM
Study NCT ID:
NCT07102095
Status:
RECRUITING
Last Update Posted:
2025-08-27
First Post:
2025-07-18
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study Evaluating How Moderate Liver Impairment Affects the Absorption, Distribution, Metabolism, and Elimination of Sevabertinib After a Single Oral Dose
Sponsor:
Bayer
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-07-24
Start Date Type:
ACTUAL
Primary Completion Date:
2026-01-23
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-01-23
Completion Date Type:
ESTIMATED
First Submit Date:
2025-07-18
First Submit QC Date:
None
Study First Post Date:
2025-08-03
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-08-21
Last Update Post Date:
2025-08-27
Last Update Post Date Type:
ESTIMATED